Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Chelsea Therapeutics
So what: There's no logical connection between the two events, and no relevant news from the company or its partner, Dainippon Sumitomo Pharma. Nothing to see here.
Now what: Chelsea is a tiny company with a volatile stock. Unless there's something I'm missing, this seems like just another market movement.
Ilan Moscovitz doesn't own shares of any company mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.